{"result": "(\"entity\"<|>NED<|>ORGANIZATION<|>NED is a nutritional support program that provides home care for elderly patients, focusing on managing their nutritional needs and improving their quality of life.)\n##\n(\"entity\"<|>REINO UNIDO<|>GEO<|>Reino Unido is a country where studies on nutritional support and its cost-effectiveness have been conducted, particularly in relation to malnutrition.)\n##\n(\"entity\"<|>NAD<|>ORGANIZATION<|>NAD refers to nutritional support that is compared to standard treatment to evaluate its economic benefits over time.)\n##\n(\"entity\"<|>EUROS<|>EVENT<|>Euros are the currency used in financial evaluations of nutritional support costs in various studies.)\n##\n(\"entity\"<|>QALY<|>EVENT<|>QALY is a measure used in health economics to assess the value of medical interventions in terms of quality and quantity of life.)\n##\n(\"entity\"<|>NED<|>ORGANIZATION<|>NED is a nutritional support program that provides home care for elderly patients, focusing on managing their nutritional needs and improving their quality of life.)\n##\n(\"entity\"<|>NPD<|>ORGANIZATION<|>NPD refers to home parenteral nutrition, a method of providing nutrition intravenously to patients who cannot eat by mouth.)\n##\n(\"entity\"<|>NUTRICIÓN ENTERAL<|>ORGANIZATION<|>Nutrición Enteral refers to enteral nutrition, which is delivered through a tube directly into the stomach or intestine.)\n##\n(\"entity\"<|>NUTRICIÓN PARENTERAL<|>ORGANIZATION<|>Nutrición Parenteral refers to parenteral nutrition, which provides nutrients intravenously to patients who cannot obtain nutrition through their digestive system.)\n##\n(\"relationship\"<|>NED<|>REINO UNIDO<|>NED has been evaluated in the context of nutritional support studies conducted in the Reino Unido<|>5)\n##\n(\"relationship\"<|>NAD<|>REINO UNIDO<|>NAD is compared to standard treatment in studies conducted in the Reino Unido to assess its cost-effectiveness<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>NED<|>NED includes the use of enteral nutrition as part of its nutritional support program<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>NED<|>NED includes the use of parenteral nutrition as part of its nutritional support program<|>7)\n##\n(\"relationship\"<|>NPD<|>REINO UNIDO<|>NPD has been analyzed for its cost-effectiveness in studies conducted in the Reino Unido<|>5)\n##\n(\"relationship\"<|>NUTRICIÓN ENTERAL<|>NAD<|>NAD includes enteral nutrition as a method of nutritional support<|>7)\n##\n(\"relationship\"<|>NUTRICIÓN PARENTERAL<|>NAD<|>NAD includes parenteral nutrition as a method of nutritional support<|>7)\n##\n(\"relationship\"<|>NED<|>NAD<|>NED is a program that evaluates the effectiveness of nutritional support, including NAD<|>6)\n##\n(\"relationship\"<|>QALY<|>NAD<|>QALY is used as a measure to evaluate the cost-effectiveness of NAD in studies<|>6)\n<|COMPLETE|>", "input": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: del cuidador «quema-\ndo», resaltando la importancia de detectar y tratar pre-\ncozmente estos trastornos.\n\nMás recientemente se han recogido los testimonios\nde 30 cuidadores de pacientes ancianos que recibían\nNED.67 La reacción inicial al comienzo de la NED fue\nnegativa, debido al miedo y ansiedad asociados al ma-\nnejo de los equipos infusores y a la imposibilidad de\nque sus familiares recibieran ingesta oral. Además de\nello, los cuidadores informales veían afectada su cali-\ndad de vida y disminuido su tiempo libre. Las visitas\nmensuales domiciliarias del equipo de NED, así como el\nentrenamiento progresivo previo al alta, se valoraron\nmuy positivamente.\n\n## 7. Impacto económico\n\nCada vez existen más publicaciones que tratan de\nevidenciar si el soporte nutricional domiciliario en la\nmalnutrición es coste-efectivo, sobre todo a largo pla-\nzo. Es decir, si la NAD comparada con el tratamiento\nestándar conlleva beneficios económicos.\n\nEn un estudio español de 2007, encontramos un\ngasto medio en NAD de 151,2 euros/paciente/mes, te-\nniendo en cuenta solo la fórmula nutricional. Al añadir\nel coste de los materiales necesarios para la administra-\nción de la NAD (sondas, jeringas, bombas, etc.) la cifra\nascendía a 159,3 euros/paciente/mes68.\n\nUna publicación reciente evalúa los costes relaciona-\ndos con la malnutrición en Reino Unido y el posible aho-\nrro con medidas de soporte nutricional, reflejando datos\nglobales de ahorro económico al implementar medidas\nde cribado, valoración nutricional y nutrición artificial.\n\n### 7.1. Suplementos orales domiciliarios\n\nDos estudios sobre suplementos al alta hospitalaria, en\npacientes ancianos malnutridos durante un período\nde 6 meses no lograron diferencias en cuanto a funciona-\nlidad, calidad de vida o coste sanitario entre el grupo con-\ntrol y de intervención69, 70. En pacientes malnutridos, con\nenfermedades gastrointestinales benignas, el uso de su-\nplementos durante 3 meses se asoció con una mejoría en\nla calidad de vida y un mayor gasto (entre 9497 y 12099\neuros/QALY), pero aparentemente coste-efectivo71.\n\nUn metanálisis reciente que incluye nueve estudios\nmuestra que la suplementación domiciliaria resulta\ncoste-efectiva o como mínimo neutra, siendo también\nlos análisis ajustados por QALY favorables en la mayo-\nría de los estudios que lo evaluaron. Además de ello, la\nsuplementación domiciliaria reduce el riesgo de hospi-\ntalización y mejora otras variables clínicas como la re-\nducción de caídas y la limitación funcional en un grupo\n\nde pacientes ancianos, y se asocia a una reducción de\ninfecciones en una cohorte de pacientes con cirrosis72.\n\n### 7.2. Nutrición enteral domiciliaria\n\nLos tratamientos con NED tienen una importante re-\npercusión en el sistema sanitario. Precisamente, en el\nReino Unido se evaluó el coste-utilidad y coste-efectivi-\ndad de la NE por sonda en pacientes con accidentes\ncerebrovasculares, tanto en domicilio como en residen-\ncias. El coste/QALY en estos pacientes ascendió a\n12817 libras, por debajo del límite habitual de 30000\nlibras/QALY. Se encontró además que la NE era\ncoste-efectiva siempre que los costes no médicos del\npaciente no estuviesen financiados por el sistema pú-\nblico. Así, en los pacientes institucionalizados, la NE\nsolo resultaba coste-efectiva cuando la contribución\nestatal representase menos del 34% del total de los\ngastos de institucionalización del enfermo73.\n\nUn estudio observacional multicéntrico posterior\nmuestra una reducción en el número de complicacio-\nnes infecciosas y del número de ingresos y del tiempo\nde hospitalización asociada a la NED, con una reduc-\nción de costes medios anuales asociados a hospitali-\nzación de 6500,20 a 2072,58 dólares74.\n\n### 7.3. Nutrición parenteral domiciliaria\n\nLos costes directos atribuibles a NPD en EEUU en el\naño 2002 oscilaban entre 75 y 122 miles de dólares\npor NPD/año, sin incluir las visitas médicas, las pruebas\nde laboratorio, el soporte de enfermería domiciliario y\nlas posibles hospitalizaciones. Los costes europeos son\nsimilares a estos descritos. En el análisis coste/utilidad,\nse mostraban unos costes hasta un\n######################\nOutput:", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": null}